# Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12

**Authors:** Gabriela E. Farias Quipildor, Ramona Belfiore, Khaled Althobaiti, Zahra Najarzadeh, Charles Glabe, Benjamin P. Readhead, Sam Gandy, Stephen R. J. Salton, Michelle E. Ehrlich

PMC · DOI: 10.1186/s44477-025-00012-x · 2026-01-19

## TL;DR

This study explores how the absence of TREM2 or TYROBP in microglia affects their signaling and behavior in Alzheimer's disease-related conditions.

## Contribution

The study reveals novel insights into the downstream signaling roles of TREM2 and TYROBP in microglial activation and morphology.

## Key findings

- Microglia lacking TREM2 or TYROBP show increased phosphorylated ERK levels and altered morphology.
- TREM2 or TYROBP deficiency leads to differential gene and protein expression in response to Alzheimer's stimuli.
- TREM2 and TYROBP are crucial for microglial homeostasis and activation in disease contexts.

## Abstract

Microglia, the primary immune cell in the brain, have multiple activation phenotypes involved in broad functions within the brain, playing roles in neurotoxicity/neuroprotection, release of inflammatory and anti-inflammatory cytokines, and in cell survival, proliferation, and phagocytosis. TREM2 and TYROBP form a transmembrane complex in microglia that modulates intracellular signaling networks, and these proteins are essential regulators of the transition from homeostatic to activated microglia. Recent findings support a TREM2-independent molecular signature that is involved in the early transition of homeostatic to disease-associated microglia (DAM), with the next sequential step of DAM activation from stage 1 to stage 2 being TREM2-dependent. However, the underlying mechanisms determining how TREM2 or TYROBP regulate these downstream phenotypes are largely unknown. We isolated primary microglia from C57BL/6 wild-type (WT) controls, Trem2 knock-out (KO), and Tyrobp KO mice at post-natal day 0–3. Cells were treated with Alzheimer’s disease (AD)-relevant stimuli, such as amyloid beta (Aβ) oligomers or fibrils, or ‘neuroinflammatory-like’ stimuli, such as lipopolysaccharide (LPS). We explored protein and gene expression in the presence or absence of inhibitors of the TREM2/TYROBP downstream signaling pathway. We also performed a high-throughput Olink proteomic analysis of conditioned media from WT, Trem2 KO, and Tyrobp KO stimulated with either LPS or Aβ oligomers or fibrils. Our results show that the absence of either TREM2 or TYROBP is associated with increased basal levels of phosphorylated ERK in primary microglia compared to WT controls. In addition, Trem2 KO and Tyrobp KO cells show a less ramified cell morphology at baseline, as compared to WT microglia. Moreover, stimulating primary microglia with either Aβ oligomers or LPS leads to differential protein and gene expression in cells lacking TREM2 or TYROBP. The dysregulated downstream signal transduction and morphology in the absence of TREM2 or TYROBP suggest their essential roles not only in microglial homeostasis but also in their activation in response to different stimuli.

The online version contains supplementary material available at 10.1186/s44477-025-00012-x.

## Linked entities

- **Genes:** TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209], TYROBP (transmembrane immune signaling adaptor TYROBP) [NCBI Gene 7305]
- **Proteins:** TREM2 (triggering receptor expressed on myeloid cells 2), TYROBP (transmembrane immune signaling adaptor TYROBP)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Tyrobp (TYRO protein tyrosine kinase binding protein) [NCBI Gene 22177] {aka DAP12, KARAP, Ly83}
- **Diseases:** neurotoxicity (MESH:D020258), neuroinflammatory (MESH:D000090862), inflammatory (MESH:D007249), AD (MESH:D000544)
- **Chemicals:** DAP12 (-), LPS (MESH:D008070)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872638/full.md

---
Source: https://tomesphere.com/paper/PMC12872638